{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T21:34:34Z","timestamp":1762032874213},"reference-count":40,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T00:00:00Z","timestamp":1270080000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH-NIAID","award":["R01 AI-56286"],"award-info":[{"award-number":["R01 AI-56286"]}]},{"name":"NIH\/National Center for Research Resources, Centers of Biomedical Excellence","award":["P20 RR-020185"],"award-info":[{"award-number":["P20 RR-020185"]}]},{"name":"Montana Agricultural Station and USDA Formula Funds"},{"name":"Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Diseases","award":["NIH U54 AI-06537"],"award-info":[{"award-number":["NIH U54 AI-06537"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1016\/j.vaccine.2010.02.022","type":"journal-article","created":{"date-parts":[[2010,3,2]],"date-time":"2010-03-02T09:49:17Z","timestamp":1267523357000},"page":"3219-3230","source":"Crossref","is-referenced-by-count":7,"title":["A parenteral DNA vaccine protects against pneumonic plague"],"prefix":"10.1016","volume":"28","author":[{"given":"Hitoki","family":"Yamanaka","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teri","family":"Hoyt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinghong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Golden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn","family":"Crist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Maddaloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David W.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.02.022_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1128\/CMR.17.2.434-464.2004","article-title":"Intraspecific diversity of Yersinia pestis","volume":"17","author":"Anisimov","year":"2004","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2010.02.022_bib2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1128\/CMR.10.1.35","article-title":"Yersinia pestis\u2014etiologic agent","volume":"10","author":"Perry","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2010.02.022_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.idc.2006.02.004","article-title":"Plague: disease, management, and recognition of act of terrorism","volume":"20","author":"Koirala","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.vaccine.2010.02.022_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4049\/jimmunol.68.2.131","article-title":"Studies on immunisation against plague","volume":"68","author":"Baker","year":"1952","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib5","first-page":"408","article-title":"An unusual strain of Pasteurella pestis isolated from a fatal human case of plague","volume":"23","author":"Winter","year":"1960","journal-title":"Bull WHO"},{"key":"10.1016\/j.vaccine.2010.02.022_bib6","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1084\/jem.20020908","article-title":"Yersinia V-antigen exploits toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression","volume":"196","author":"Sing","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.02.022_bib7","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1128\/IAI.63.8.2854-2858.1995","article-title":"Active immunisation with V-antigen from Yersinia pestis protects against plague","volume":"63","author":"Leary","year":"1995","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.02.022_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1574-695X.1998.tb01168.x","article-title":"Macromolecular organisation of recombinant Yersinia pestis F1 antigen and effect of structure on immunogenicity","volume":"21","author":"Miller","year":"1998","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0264-410X(98)80110-2","article-title":"Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine","volume":"16","author":"Heath","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.02.022_bib10","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1574-695X.1995.tb00196.x","article-title":"A new improved sub-unit vaccine for plague: the basis of protection","volume":"12","author":"Williamson","year":"1995","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0264-410X(96)00303-9","article-title":"A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washing and protects immunized animals against pneumonic plague","volume":"15","author":"Williamson","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.02.022_bib12","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0264-410X(96)00151-X","article-title":"Local and systemic immune response to a microencapsulated sub-unit vaccine for plague","volume":"14","author":"Williamson","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.02.022_bib13","doi-asserted-by":"crossref","first-page":"7304","DOI":"10.1128\/IAI.73.11.7304-7310.2005","article-title":"Cell-mediated protection against pulmonary Yersinia pestis infection","volume":"73","author":"Parent","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.02.022_bib14","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/IAI.00185-06","article-title":"Gamma interferon, tumor necrosis factor alpha, and nitric oxide synthase 2, key elements of cellular immunity, perform critical protective functions during humoral defense against lethal pulmonary Yersinia pestis infection","volume":"74","author":"Parent","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.02.022_bib15","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1128\/IAI.01529-06","article-title":"Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection","volume":"75","author":"Philipovskiy","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.02.022_bib16","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1126\/science.7973732","article-title":"Lymphotactin: a cytokine that represents a new class of chemokine","volume":"266","author":"Kelner","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.02.022_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.4049\/jimmunol.155.1.203","article-title":"Molecular cloning and functional characterization of human lymphotactin","volume":"155","author":"Kennedy","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib18","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.4049\/jimmunol.158.4.1533","article-title":"Lymphotactin is produced by NK cells and attracts both NK cells and T cells in vivo","volume":"158","author":"Hedrick","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib19","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1006\/clin.1998.4546","article-title":"Lymphotactin","volume":"87","author":"Hedrick","year":"1998","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib20","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/eji.1830250638","article-title":"Cloning of ATAC, an activation-induced, chemokine-related molecule exclusively expressed in CD8+ T lymphocytes","volume":"25","author":"Muller","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib21","doi-asserted-by":"crossref","first-page":"16551","DOI":"10.1074\/jbc.273.26.16551","article-title":"Identification of single C motif-1\/lymphotactin receptor XCR1","volume":"273","author":"Yoshida","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2010.02.022_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-5793(99)01114-X","article-title":"Molecular cloning of mXCR1, the murine SCM-1\/lymphotactin receptor","volume":"458","author":"Yoshida","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2010.02.022_bib23","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4049\/jimmunol.157.3.985","article-title":"Chemokine expression by intraepithelial \u03b3\u03b4 T cells. Implications for the recruitment of inflammatory cells to damaged epithelia","volume":"157","author":"Boismenu","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib24","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.4049\/jimmunol.162.4.1959","article-title":"Lymphotactin acts as an innate mucosal adjuvant","volume":"162","author":"Lillard","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib25","doi-asserted-by":"crossref","first-page":"4564","DOI":"10.1128\/IAI.00581-08","article-title":"A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague","volume":"76","author":"Yamanaka","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.02.022_bib26","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.4049\/jimmunol.177.8.5524","article-title":"Mucosal vaccine targeting improves onset of mucosal and systemic immunity to botulinum neurotoxin A (BoNT\/A)","volume":"177","author":"Maddaloni","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib27","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.4049\/jimmunol.178.2.1059","article-title":"Oral vaccination with Salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague","volume":"178","author":"Yang","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib28","doi-asserted-by":"crossref","first-page":"7297","DOI":"10.1128\/IAI.73.11.7297-7303.2005","article-title":"Selection of protective epitopes for Brucella melitensis using DNA vaccination","volume":"73","author":"Yang","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.02.022_bib29","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4049\/jimmunol.178.3.1791","article-title":"Regulatory T cell vaccination without autoantigen protects against experimental autoimmune encephalomyelitis","volume":"178","author":"Ochoa-Rep\u00e1raz","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib30","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1128\/IAI.70.8.4273-4281.2002","article-title":"Fimbriated Salmonella enterica serovar Typhimurium abates initial inflammatory responses by macrophages","volume":"70","author":"Pascual","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2010.02.022_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.vaccine.2008.10.021","article-title":"An IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plague","volume":"27","author":"Yamanaka","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.02.022_bib32","doi-asserted-by":"crossref","first-page":"6238","DOI":"10.4049\/jimmunol.161.11.6238","article-title":"Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity","volume":"161","author":"Cao","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib33","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/nm1096-1090","article-title":"Combined chemokine and cytokine gene transfer enhances antitumor immunity","volume":"2","author":"Dilloo","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2010.02.022_bib34","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/vim.2004.17.545","article-title":"Effects of virus burden and chemokine expression on immunity to SHIV in nonhuman primates","volume":"17","author":"Waterman","year":"2004","journal-title":"Viral Immunol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib35","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0264-410X(01)00270-5","article-title":"Adjuvant effects of IL-1\u03b2, IL-2 IL-8, IL-15, IFN-\u03b1, IFN-\u03b3, TGF-\u03b24 and lymphotactin on DNA vaccination against Eimeria ecervulina","volume":"20","author":"Min","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.02.022_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1089\/aid.2005.21.629","article-title":"Priming with plasmid DNAs expressing interleukin-12 and simian immunodeficiency virus gag enhances the immunogenicity and efficacy of an experimental AIDS vaccine based on recombinant vesicular stomatitis virus","volume":"21","author":"Egan","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/j.vaccine.2010.02.022_bib37","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.virol.2005.12.029","article-title":"Immunization of rhesus macaques with a polyvalent DNA prime\/protein boost human immunodeficiency virus type 1 vaccine elicits protective antibody response against simian human immunodeficiency virus of R5 phenotype","volume":"348","author":"Pal","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2010.02.022_bib38","doi-asserted-by":"crossref","first-page":"4621","DOI":"10.4049\/jimmunol.155.10.4621","article-title":"Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4","volume":"155","author":"Marinaro","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2010.02.022_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.181.1.41","article-title":"Impaired mucosal immune responses in interleukin 4-targeted mice","volume":"181","author":"Vajdy","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.02.022_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2249.1999.00859.x","article-title":"An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model","volume":"116","author":"Williamson","year":"1999","journal-title":"Clin Exp Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10001908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10001908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T17:53:54Z","timestamp":1685469234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10001908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":40,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2010,4]]}},"alternative-id":["S0264410X10001908"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.02.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}